A Study of the Safety and PK of PCS6422 (Eniluracil) With Capecitabine in Patients With Advanced, Refractory GI Tract Tumors Read more about A Study of the Safety and PK of PCS6422 (Eniluracil) With Capecitabine in Patients With Advanced, Refractory GI Tract Tumors
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors Read more about PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer Read more about Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma Read more about A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer Read more about Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread Read more about Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
Comparing Two Methods to Follow Patients With Pancreatic Cysts Read more about Comparing Two Methods to Follow Patients With Pancreatic Cysts
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer Read more about BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Read more about Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV Read more about Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV